S'abonner

Carrying on with liver transplantation during the COVID-19 emergency: Report from piedmont region - 26/08/20

Doi : 10.1016/j.clinre.2020.07.017 
Margherita Saracco a, 1, Silvia Martini a, , 1 , Francesco Tandoi b, Dominic Dell’Olio c, Antonio Ottobrelli a, Antonio Scarmozzino d, Antonio Amoroso c, Paolo Fonio e, Roberto Balagna f, Renato Romagnoli b
a Gastrohepatology Unit, AOU Città della Salute e della Scienza di Torino, University of Turin, Turin, Italy 
b General Surgery 2U, Liver Transplantation Center, AOU Città della Salute e della Scienza di Torino, University of Turin, Turin, Italy 
c Regional Transplantation Center, Piedmont, AOU Città della Salute e della Scienza di Torino, University of Turin, Turin, Italy 
d Molinette Hospital, AOU Città della Salute e della Scienza di Torino, Turin, Italy 
e Radiology Unit, AOU Città della Salute e della Scienza di Torino, University of Turin, Turin, Italy 
f Anesthesia and Intensive Care Unit 2, AOU Città della Salute e della Scienza di Torino, Turin, Italy 

Correspondence author.

Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.

Connectez-vous pour en bénéficier!

Sous presse. Épreuves corrigées par l'auteur. Disponible en ligne depuis le Wednesday 26 August 2020
Cet article a été publié dans un numéro de la revue, cliquez ici pour y accéder

Highlights

The COVID-19 pandemic is a public health emergency affecting all aspects of medical care, included liver transplant activity.
We aimed to analyze if our strategy and organization of LT pathway during the first two months of the COVID-19 emergency succeeded in keeping a high level of LT activity.
We compared the number of LT in the first two months with the same period of time in 2019, in our high-volume transplant Center (median 150 L T/year).
Team working with close involvement of several specialties allowed our single regional Center to maintain its activity level, taking care of patients before and after LT.
We think that LT, being a life-saving procedure, should be not suspended when it is possible. Sharing our experience, we hope to be helpful to other Transplant Centers that are now facing the COVID-19 emergency.

Le texte complet de cet article est disponible en PDF.

Summary

Background

The COVID-19 pandemic is an emergency worldwide. In Italy, liver transplant activity was carried on, but despite all efforts, a 25% reduction of procured organs has already been observed during the first 4 weeks of the outbreak.

Aims

To analyze if our strategy and organization of LT pathway during the first two months of the COVID-19 emergency succeeded in keeping a high level of LT activity, comparing the number of LT in the first two months with the same period of time in 2019.

Methods

We compared the liver transplants performed in our Center between February 24th and April 17th, 2020 with liver transplants performed in the same period in 2019.

Results

In 2020, 21 patients underwent liver transplantation from deceased donors, exactly as the year before, without statistically significant difference. All patients survived in both groups, and the rate of early graft dysfunction was 24% in 2020 and 33% in 2019. In 2020 Median MELD was higher (17 vs 13). We were able to perform 3 multiorgan transplants and one acute liver failure. Nobody died on waiting list. The performance of our Center, despite the maxi-emergency situation, was steady and this was the result of a tremendous team working within the hospital and in our region.

Conclusions

Team working allowed our Center to maintain its activity level, taking care of patients before and after liver transplantation. Sharing our experience, we hope to be helpful to other Centers that are facing the pandemic and, if another pandemic comes, to be more prepared to deal with it.

Le texte complet de cet article est disponible en PDF.

Abbreviations : AIH, ALF, ASSLD, BAL, CIT, CNT, EAD, EASL, HCC, HOPE, ICU, LT, MELD, NASH, NPS, WHO

Keywords : SARS-CoV-2, Outbreak, Transplant activity, Tertiary healthcare, Team working


Plan


© 2020  Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Bienvenue sur EM-consulte, la référence des professionnels de santé.

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.